v3.26.1
Stock Plans (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Compensation Expense
Stock compensation expense, included in Selling, general and administrative expense in the unaudited Condensed Consolidated Statements of Income, is as follows:
Three Months Ended June 30,Six Months Ended June 30,
(In thousands)2026202520262025
Stock compensation expense$7,809 $5,370 $11,621 $7,999 
Income tax benefit1,866 1,327 2,777 1,976 
Stock compensation expense, net of tax$5,943 $4,043 $8,844 $6,023 
We have not capitalized any stock-based compensation expense.
Summary of Stock Option Activity
A summary of stock option activity for the six months ended June 30, 2026, is as follows:
SharesWeighted Average
Exercise Price
Outstanding at January 1, 20262,217 $48.30 
Exercised(510)44.59 
Outstanding and exercisable at June 30, 20261,707 $49.41 
Summary of Restricted Stock and Unit Activity A summary of restricted stock activity for the six months ended June 30, 2026, is as follows:
SharesWeighted Average
Grant Date
Fair Value
Unvested at January 1, 2026168,387 $159.38 
Granted59,124 190.27 
Vested(56,632)141.59 
Forfeited(9,762)178.66 
Unvested at June 30, 2026161,117 $175.80 
Schedule of Fair Value Assumptions for Units The following weighted average assumptions were used in estimating the fair value of the performance stock units granted in the first quarter of 2026:
Fair value per unit$223.21
Risk-free interest rate3.52%
Expected dividend yield1.27%
Expected volatility23.2%
MSA stock beta0.725
Summary of Performance Stock Unit Activity
A summary of performance stock unit activity for the six months ended June 30, 2026, is as follows:
SharesWeighted Average
Grant Date
Fair Value
Unvested at January 1, 2026151,552 $153.00 
Granted51,565 222.96 
Performance adjustments(a)
49,804 131.46 
Vested(111,975)131.46 
Forfeited(7,680)185.99 
Unvested at June 30, 2026133,266 $188.21 
(a) Performance adjustments relate primarily to the final number of shares issued for the 2023 performance unit awards which vested in the first quarter of 2026 at 180% of the target award based on both cumulative performance against EBITDA margin and revenue growth targets and MSA's total shareholder return during the three-year performance period.